AI Terminal
Fresenius Medical Care AG & Co. KGaA
Transaction in Own Shares • Apr 3, 2020
165_rns_2020-04-03_99746837-480e-43f5-bbec-3393bd047f3a.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
News Details
Other Capital Market Information | 3 April 2020 10:10
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
03.04.2020 / 10:10
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
– Share buy-back – 42 nd Interim Report and Final Report
In the period from March 30, 2020 until and including April 1, 2020, a total of 1,906,796 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):
XETRA
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 30.03.2020 | 507,449 | 58.1217 |
| 31.03.2020 | 498,159 | 59.7579 |
| 01.04.2020 | 538,530 | 59.3516 |
Chi-X Europe
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 30.03.2020 | 78,533 | 58.1681 |
| 31.03.2020 | 71,899 | 59.7985 |
| 01.04.2020 | 99,953 | 59.3799 |
BATS Europe
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 30.03.2020 | 11,516 | 58.2242 |
| 31.03.2020 | 19,031 | 59.7440 |
| 01.04.2020 | 31,370 | 59.4862 |
Turquoise
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 30.03.2020 | 13,694 | 58.0568 |
| 31.03.2020 | 11,702 | 59.6980 |
| 01.04.2020 | 24,960 | 59.2190 |
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including April 1, 2020 therefore amounts to 10,795,151 shares. The weighted average share price paid for these shares amounted to EUR 61.0270. This concludes the share buy-back programme.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., April 3, 2020
03.04.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |